Cargando…

Risk for primary cephalosporin resistance in Gram-negative bacteremia

OBJECTIVE: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). METHODS: This retrospective cohort study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Princy, Shahbazian, Sona, Lainhart, William D., Hayes, Justin, Mochon, Brian, Nix, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369432/ https://www.ncbi.nlm.nih.gov/pubmed/37502246 http://dx.doi.org/10.1017/ash.2023.202

Ejemplares similares

1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia
por: Shah, Sunish, et al.
Publicado: (2018)

Fluoroquinolones Protective against Cephalosporin Resistance in Gram-negative Nosocomial Pathogens
por: Schwaber, Mitchell J., et al.
Publicado: (2004)

Impact of Verigene Multiplex PCR for Positive Blood Cultures and Gram-negative Bacteremia
por: Adams, Matthew, et al.
Publicado: (2017)

Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)

1285. Outcomes in Patients with Gram-Negative Bacteremia from Phase 2 and Phase 3 Clinical Trials of Cefiderocol, a Novel Siderophore Cephalosporin
por: Kinoshita, David PatersonDavid PatersonMasahiro, et al.
Publicado: (2020)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

Antimicrobial resistance pattern of gram negative bacteria to 3rd and 4th generation cephalosporins
por: Revathi, P, et al.
Publicado: (2011)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
por: Mushtaq, Shazad, et al.
Publicado: (2020)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania
por: Christopher, Alexandra, et al.
Publicado: (2013)

Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern
por: Park, Sun Hee
Publicado: (2014)

Impact of Persistent Multidrug-Resistant Gram-Negative Bacteremia on Clinical Outcome and Mortality
por: Kitaya, Shiori, et al.
Publicado: (2023)

Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010)

Strongyloidiasis complicated by gram-negative bacteremia and liver abscesses
por: Ordaya, Eloy E., et al.
Publicado: (2022)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2022)

Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae
por: Christodoulou, S., et al.
Publicado: (2017)

Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis
por: Moghnieh, Rima, et al.
Publicado: (2015)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
por: Shi, Hye Jin, et al.
Publicado: (2020)

Prevalence and Emergence of Extended-Spectrum Cephalosporin-, Carbapenem- and Colistin-Resistant Gram Negative Bacteria of Animal Origin in the Mediterranean Basin
por: Dandachi, Iman, et al.
Publicado: (2018)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
por: Ito, Akinobu, et al.
Publicado: (2017)

252 S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

Procalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
por: Guo, Shun Yuan, et al.
Publicado: (2015)

Analysis of Gram-negative rod bacteremia in the surgical and medical ICU
por: Adukauskiene, D, et al.
Publicado: (2015)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

Proposal of a clinical score to stratify the risk of multidrug-resistant gram-negative rods bacteremia in cancer patients
por: Carena, Alberto A., et al.
Publicado: (2019)

1545. Gram-Negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
por: Herrera, Fabián, et al.
Publicado: (2018)

Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli
por: Maurya, Anand Prakash, et al.
Publicado: (2015)

Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken
por: McLellan, Jade E., et al.
Publicado: (2018)

From Farms to Markets: Gram-Negative Bacteria Resistant to Third-Generation Cephalosporins in Fruits and Vegetables in a Region of North Africa
por: Mesbah Zekar, Ferielle, et al.
Publicado: (2017)

Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study
por: de la Court, Jara R., et al.
Publicado: (2022)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

216. A Comparison of Multidrug-Resistant Gram-negative Bacteremia in Cancer and Non-Cancer Patients
por: Haris Khan, Muhammad, et al.
Publicado: (2023)

244. Predictors and Outcomes of Multi-Drug Resistant Gram-Negative Bacteremia in Patients with Solid Tumours
por: Varghese, George M, et al.
Publicado: (2023)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
por: Saisho, Yutaka, et al.
Publicado: (2018)

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
por: Katsube, Takayuki, et al.
Publicado: (2016)

Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2013)

Gram-negative bacteremia is an independent predisposing factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nn02sfd7ldvskct5hu05v7nmd0